ST88-14 (Q54955754)

From Wikidata

Jump to navigation Jump to search

cell line

ST88.14
ST 88-14
ST-8814
ST8814
88-14
NF188-14

Language	Label	Description	Also known as
English	ST88-14	cell line	ST88.14 ST 88-14 ST-8814 ST8814 88-14 NF188-14

Statements

1 reference

Cellosaurus release 44

31 January 2023

cancer cell line

1 reference

Cellosaurus release 44

31 January 2023

described by source

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis

1 reference

Cellosaurus release 44

31 January 2023

Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype

1 reference

Cellosaurus release 44

31 January 2023

Neurofibrosarcoma-derived Schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF BB.

1 reference

Cellosaurus release 44

31 January 2023

Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models

1 reference

Cellosaurus release 44

31 January 2023

The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell lines

1 reference

Cellosaurus release 44

31 January 2023

Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues

1 reference

Cellosaurus release 44

31 January 2023

EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy

1 reference

Cellosaurus release 44

31 January 2023

Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors

1 reference

Cellosaurus release 44

31 January 2023

Oncogene Mutation Survey in MPNST Cell Lines Enhances the Dominant Role of Hyperactive Ras in NF1 Associated Pro-Survival and Malignancy

1 reference

Cellosaurus release 44

31 January 2023

Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS.

1 reference

Cellosaurus release 44

31 January 2023

TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities

1 reference

Cellosaurus release 44

31 January 2023

Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression

1 reference

Cellosaurus release 44

31 January 2023

Comprehensive pharmacological profiling of neurofibromatosis cell lines

1 reference

Cellosaurus release 44

31 January 2023

Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis

1 reference

Cellosaurus release 44

31 January 2023

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors

1 reference

Cellosaurus release 44

31 January 2023

Genetics of human malignant peripheral nerve sheath tumors

1 reference

Cellosaurus release 44

31 January 2023

established from medical condition

malignant peripheral nerve sheath tumor

1 reference

Cellosaurus release 44

31 January 2023

derived from organism type

1 reference

Cellosaurus release 44

31 January 2023

http://purl.obolibrary.org/obo/EFO_0006295

1 reference

Cellosaurus release 44

31 January 2023

Identifiers

1 reference

Cellosaurus release 44

31 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54955754&oldid=1861749351"